Generics 87

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Doxylamine succinate manufacturers

87 products found

Filters

87 products found

doxylamine succinate

Tablets 12.5 mg, 25 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
OTC
Manufacturer #958
A pharmaceutical manufacturer based in the EU that has been active in 40+ countries selling its products in Europe, the Middle East, LATAM, Africa, and Asia for 10+ years. Key production lines are Rx, OTC, and medical devices. Main therapeutic areas include oncology, CNS, and respiratory.

Manufacturer usually replies in 8 days

doxylamine succinate

Tablets, film coated 12.5 mg, 25 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Spain , Poland
Registered in
Spain , Poland
Available for
Licensing with supply, Technology transfer
Manufacturer #1186
A pharmaceutical manufacturer based in the EU that has been active for 20+ years. Key production lines are Rx products, generic products, OTC products, and nutraceuticals with cGMP standards. Therapy areas include coughs, flu, and pain killers. The company has its R&D and regulatory affairs unit that provides for CTD/eCTD dossier and ICH stability study. The company can produce in most pharmaceutical forms.

Manufacturer usually replies in 18 days

doxylamine succinate + pyridoxine hydrochloride

Tablets, delayed release (DR) 10 mg + 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Unavailable markets
Saudi Arabia , Algeria , Bahrain , Egypt , Iran , Iraq , Israel , Jordan , Kuwait , Lebanon , Libya , Morocco , Oman , Qatar , Syria , Tunisia , United Arab Emirates
Manufacturer #17778
The organization is made up of five pharmaceutical companies that work together to satisfy the requirements of patients in Canada, the United States, and other countries. The company exports its revolutionary therapies to more than 50 countries from its state-of-the-art production site in North America. They offer novel solutions for several medical disorders in women's health, urology, oncology, and rare diseases through their research and development and partnerships.

Manufacturer usually replies in 2 days

doxylamine succinate + pyridoxine hydrochloride + folic acid

Tablets 10 mg + 10 mg + 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
MAs for sale
India
Manufacturer #22627

Manufacturer usually replies in 4 days

doxylamine succinate + pyridoxine hydrochloride

Tablets 10 mg + 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
India
Manufacturer #21247

Manufacturer usually replies in 3 days

doxylamine succinate + vitamin b6

Tablets 10 mg + 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
India
Manufacturer #21247

Manufacturer usually replies in 3 days

doxylamine succinate + pyridoxine hydrochloride + folic acid

Tablets 10 mg + 10 mg + 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21177

Manufacturer usually replies in 12 days

doxylamine succinate + pyridoxine hydrochloride + folic acid

Tablets 10 mg + 10 mg + 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20848

Manufacturer usually replies in 3 days

doxylamine succinate

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20848

Manufacturer usually replies in 3 days

doxylamine succinate + pyridoxine hydrochloride

Tablets 10 mg + 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20299

Manufacturer usually replies in 1 days

doxylamine succinate + folic acid + pyridoxine hydrochloride

Tablets 10 mg + 2.5 mg + 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20221

Manufacturer usually replies in 5 days

doxylamine succinate + pyridoxine + folic acid

Tablets 10 mg + 10 mg + 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20360

Manufacturer usually replies in 1 days

doxylamine succinate + pyridoxine hydrochloride + folic acid

Tablets 10 mg+10 mg+2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19472

Manufacturer usually replies in 4 days

doxylamine succinate + pyridoxine hydrochloride

Tablets 20 mg+20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19472

Manufacturer usually replies in 4 days

doxylamine succinate + pyridoxine hydrochloride + folic acid

Tablets 10 mg+10 mg+2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19378

Manufacturer usually replies in 4 days

doxylamine succinate + vitamine b6 + folic acid

Tablets 10 mg+10 mg+1.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19307

Manufacturer usually replies in 3 days

doxylamine succinate + pyridoxine + folic acid

Tablets 10 mg+10 mg+1.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17091

Manufacturer usually replies in 5 days

doxylamine succinate + pyridoxine + folic acid

Tablets 20 mg+20 mg+ 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19017

Manufacturer usually replies in 4 days

doxylamine succinate + pyridoxine

Tablets 10 mg + 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18285

Manufacturer usually replies in 3 days

doxylamine succinate + pyridoxine hydrochloride + folic acid

Tablets 10 mg + 10 mg + 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18271

Manufacturer usually replies in 4 days

Want to view all 87 products? Create your free account today!

Doxylamine succinate:

Doxylamine succinate is a medication belonging to a group of pharmaceutical products termed first-generation antihistamines. It is used to treat a variety of indications, most commonly as a short-term sedative and hypnotic. Doxylamine succinate manufacturers and doxylamine succinate suppliers also typically list it for sale in combination formulations with other drugs, this confers additional night-time allergy and cold relief. A common combination sold by distributors is preparations containing analgesics paracetamol (acetaminophen) and codeine, which aid in that calmative effect. It is also produced by manufacturers in combination with vitamin B6 (pyridoxine) to prevent morning sickness in pregnant women.
Currently, doxylamine succinate can be found on manufacturers and distributors pharmaceutical products wholesale list at a variety of price points. This is largely driven by doxylamine succinate’s wide regulatory acceptance and emerged generic nature, since its first discovery and patent in 1949. This has made it both attractive and cost-effective for suppliers to list in their global B2B drugs portfolio.

Method of action of Doxylamine succinate:

Doxylamine succinate is an antihistamine belonging to ethanolamine class, with powerful antihistamine and anti-allergy effects. It is one of the most powerful over the counter sedatives available for purchase in the United States and functions through its competitive action binding to the H1 receptor. This prevents histamine from binding, resulting in the sedative and anti-allergic effects. Doxylamine also acts as an antagonist of the muscarinic acetylcholine receptors, causing a series of downstream actions, which result in its minor hypnotic, anticholinergic, and (at high doses) deliriant effects.

Form and dosage of doxylamine succinate:

As with all drugs, the final form and packaging are dependent on the manufacturers and suppliers, as well as the distributor and specific order. However, doxylamine succinate typically comes in forms such as tablets, film-coated tablets, capsules, liquid capsules, oral solutions, chewable tablets, and prolonged-release tablets. It is an over the counter medication, as such it does not require a specific prescription for use. Normal doses vary based on the individual and the underlying indication. However, manufacturers recommend 25 mg orally once a day, 30 minutes before bed for the treatment of adults suffering from insomnia. For the adult treatment of allergies, a recommended dose is 50 mg orally every 4-6 hours as needed. Caution should be applied if continued use passes two weeks, if so, it would be prudent to bring this up with a professional healthcare provider.

Doxylamine succinate on Pipelinepharma:

Currently, we have found 4 trusted doxylamine succinate manufacturers and doxylamine succinate suppliers from our global list of online B2B sellers. These manufacturers and wholesale sellers are located in countries including the European Union, India, and Argentina. Every company on our online B2B marketplace has been verified by the Pipelinepharma team according to strict quality control. This ensures seller legitimacy and reduces sourcing mileage, facilitating a quick and pain-free transaction experience.

Price of doxylamine succinate and how to buy:

As with all pharmaceutical products, the cost of doxylamine succinate is highly dependent on numerous factors such as organisation, quantity, and location. However, a cursory search online reveals the typical cost for wholesale purchase is approximately in the range of USD 8 for 20 mg of Doxylamine Succinate. Although specific prices remain confidential between both B2B parties on the online Pipelinepharma marketplace, sellers may choose to list the desired price for their product to facilitate negotiations. If so, this will be indicated with an ‘Accept’ and ‘Negotiate’ button. In the absence of a listed price a ‘Get offer’ button will instead be displayed.